Literature DB >> 1992962

Ventricular tachycardia during routine treadmill testing. Risk and prognosis.

J C Yang1, R C Wesley, V F Froelicher.   

Abstract

Exercise-induced ventricular tachycardia during exercise testing is considered to increase risk during testing. Moreover, exercise-induced ventricular tachycardia has been considered to confer a poor prognosis although this has not been specifically studied. On a retrospective review of 3351 patients who had undergone routine clinical exercise testing between September 1984 and June 1989, we identified 55 patients with exercise-induced ventricular tachycardia. The mean follow-up was 26 months (range, 2 to 58 months). Fifty patients had nonsustained ventricular tachycardia during exercise testing and one of these patients died due to congestive heart failure during the follow-up period. Five patients had sustained ventricular tachycardia during exercise testing and one died suddenly 7 months after the test. Ventricular tachycardia was reproduced in only two of the 29 patients who underwent repeated exercise testing. Ventricular tachycardia during routine clinical exercise testing occurred rarely (prevalence of 1.5%) and was not associated with complications during testing. The total mortality in the exercise-induced ventricular tachycardia group (3.6%) was not significantly different from the mortality in the entire population (5.1%). Nonsustained ventricular tachycardia occurring during clinical exercise testing is not an independent marker of a poor prognosis.

Entities:  

Mesh:

Year:  1991        PMID: 1992962

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  9 in total

Review 1.  Peptide synthesis through evolution.

Authors:  K Tamura; R W Alexander
Journal:  Cell Mol Life Sci       Date:  2004-06       Impact factor: 9.261

Review 2.  [Complications during exercise testing].

Authors:  R Berent; J Auer; S P von Duvillard; H Sinzinger; P Schmid
Journal:  Herz       Date:  2011-11-17       Impact factor: 1.443

3.  Prognostic significance of exercise-induced premature ventricular complexes: a systematic review and meta-analysis of observational studies.

Authors:  Victor Lee; Dhanuka Perera; Pier Lambiase
Journal:  Heart Asia       Date:  2017-01-04

4.  Prevalence and prognostic significance of exercise-induced nonsustained ventricular tachycardia in asymptomatic volunteers: BLSA (Baltimore Longitudinal Study of Aging).

Authors:  Joseph E Marine; Veena Shetty; Grant V Chow; Jeanette G Wright; Gary Gerstenblith; Samer S Najjar; Edward G Lakatta; Jerome L Fleg
Journal:  J Am Coll Cardiol       Date:  2013-06-07       Impact factor: 24.094

5.  Disordered autonomic function during exposure to moderate heat or exercise in a mouse model of Dravet syndrome.

Authors:  Nikhil Sahai; Angela M Bard; Orrin Devinsky; Franck Kalume
Journal:  Neurobiol Dis       Date:  2020-11-02       Impact factor: 5.996

6.  Favourable outcome in idiopathic ventricular fibrillation with treatment aimed at prevention of high sympathetic tone and suppression of inducible arrhythmias.

Authors:  H J Crijns; A C Wiesfeld; J L Posma; K I Lie
Journal:  Br Heart J       Date:  1995-10

7.  Exercise induced non-sustained ventricular tachycardia and indication for invasive management.

Authors:  Shahriar Dadkhah; Samaneh Dowlatshahi; Korosh Sharain; Roza Sharain
Journal:  Clin Med Insights Cardiol       Date:  2011-11-17

8.  Exercise-Induced Sustained Ventricular Tachycardia without Structural Heart Disease: A Case Report.

Authors:  Michelle Audrey Darmadi; Axel Duval; Hanaa Khadraoui; Alberto N Romero; Blanca Simon; Justyna Watkowska; Henock Saint-Jacques
Journal:  Am J Case Rep       Date:  2020-12-10

9.  Effect of burden and origin sites of premature ventricular contractions on left ventricular function by 7-day Holter monitor.

Authors:  Wenhua Xu; Mingfang Li; Minglong Chen; Bing Yang; Daowu Wang; Xiangqing Kong; Hongwu Chen; Weizhu Ju; Kai Gu; Kejiang Cao; Hailei Liu; Qi Jiang; Jiaojiao Shi; Yan Cui; Hong Wang
Journal:  J Biomed Res       Date:  2015-06-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.